| Literature DB >> 32601447 |
José Fernando Maya-Vetencourt1,2,3, Giovanni Manfredi4, Maurizio Mete5, Elisabetta Colombo1,2, Mattia Bramini1,6, Stefano Di Marco1,2, Dmytro Shmal1, Giulia Mantero1, Michele Dipalo7, Anna Rocchi1,2, Mattia L DiFrancesco1, Ermanno D Papaleo1, Angela Russo5, Jonathan Barsotti4, Cyril Eleftheriou1,8, Francesca Di Maria9, Vanessa Cossu2,10, Fabio Piazza11, Laura Emionite2, Flavia Ticconi2,10,12, Cecilia Marini13, Gianmario Sambuceti2,10, Grazia Pertile5, Guglielmo Lanzani14,15, Fabio Benfenati16,17.
Abstract
Inherited retinal dystrophies and late-stage age-related macular degeneration, for which treatments remain limited, are among the most prevalent causes of legal blindness. Retinal prostheses have been developed to stimulate the inner retinal network; however, lack of sensitivity and resolution, and the need for wiring or external cameras, have limited their application. Here we show that conjugated polymer nanoparticles (P3HT NPs) mediate light-evoked stimulation of retinal neurons and persistently rescue visual functions when subretinally injected in a rat model of retinitis pigmentosa. P3HT NPs spread out over the entire subretinal space and promote light-dependent activation of spared inner retinal neurons, recovering subcortical, cortical and behavioural visual responses in the absence of trophic effects or retinal inflammation. By conferring sustained light sensitivity to degenerate retinas after a single injection, and with the potential for high spatial resolution, P3HT NPs provide a new avenue in retinal prosthetics with potential applications not only in retinitis pigmentosa, but also in age-related macular degeneration.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32601447 DOI: 10.1038/s41565-020-0696-3
Source DB: PubMed Journal: Nat Nanotechnol ISSN: 1748-3387 Impact factor: 39.213